{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:49:59Z","timestamp":1790293799088,"version":"4.1.0"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21871180"],"award-info":[{"award-number":["21871180"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["18520710300"],"award-info":[{"award-number":["18520710300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["18JC1413500"],"award-info":[{"award-number":["18JC1413500"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Due to the high morbidity and mortality of cardiovascular diseases, there is an urgent need for research on antithrombotic strategies. In view of the short half-life, insufficient drug penetration, poor targeting capabilities, and hemorrhagic side-effects of traditional thrombus treatment methods, the combination of thrombolytic therapy and nanocarriers brought by the development of nanotechnology in recent years may provide effective solutions for these undesirable side-effects caused by insufficient targeting. Polymeric nanocarriers, based on macromolecules and various functional groups, can connect specific targeting molecules together through chemical modification to achieve the protection and targeted delivery of thrombolytic drugs. However, simple chemical molecular modifications may be easily affected by the physiological environment encountered in the circulatory system. Therefore, the modification of nanocarriers with cell membranes can provide camouflage to these platforms and help to extend their circulation time while also imparting them with the biological functions of cell membranes, thus providing them with precise targeting capabilities, among which the most important is the biological modification of platelet membranes. In addition, some nanoparticles with their own therapeutic functions have also been developed, such as polypyrrole, which can exhibit a photothermal effect to induce thrombolysis. Herein, combined with the mechanism of thrombosis and thrombolysis, we outline the recent advances achieved with thrombus-targeting nanocarriers with regard to thrombosis treatment. On this basis, the design considerations, advantages, and challenges of these thrombolytic therapies in clinical transformation are discussed.<\/jats:p>","DOI":"10.3389\/fphys.2021.763085","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T18:18:30Z","timestamp":1638382710000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in Thrombolytic Therapy"],"prefix":"10.3389","volume":"12","author":[{"given":"Qixiao","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjing","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,30]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.thromres.2019.05.020","article-title":"The efficacy and safety of anticoagulation in cerebral vein thrombosis: A systematic review and meta-analysis","volume":"180","author":"Al Rawahi","year":"2019","journal-title":"Thromb. Res."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1161\/atvbaha.120.315754","article-title":"Thrombus structural composition in cardiovascular disease","volume":"41","author":"Alkarithi","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fmolb.2021.680397","article-title":"Role of Fibrinolytic enzymes in anti-thrombosis therapy","volume":"8","author":"Altaf","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.freeradbiomed.2021.02.012","article-title":"Influence of cardiometabolic comorbidities on myocardial function, infarction, and cardioprotection: role of cardiac redox signaling","volume":"166","author":"Andreadou","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bbagen.2008.10.008","article-title":"Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets","volume":"1790","author":"Bachelet","year":"2009","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1039\/d0bm00818d","article-title":"Multimodal and multifunctional nanoparticles with platelet targeting ability and phase transition efficiency for the molecular imaging and thrombolysis of coronary microthrombi","volume":"8","author":"Bai","year":"2020","journal-title":"Biomater. Sci."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"CD012534","DOI":"10.1002\/14651858.CD012534.pub2","article-title":"Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies","volume":"7","author":"Bala","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.thromres.2006.04.013","article-title":"Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb\/IIIa) receptor","volume":"119","author":"Barre","year":"2007","journal-title":"Thromb. Res."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"E33","DOI":"10.1161\/cir.0000000000000746","article-title":"Heart disease and stroke Statistics-2019 update: A report From the American Heart Association","volume":"141","author":"Benjamin","year":"2020","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.actbio.2019.06.053","article-title":"A bioinspired hyperthermic macrophage-based polypyrrole-polyethylenimine (Ppy-PEI) nanocomplex carrier to prevent and disrupt thrombotic fibrin clots","volume":"96","author":"Burnouf","year":"2019","journal-title":"Acta Biomater."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.addr.2020.09.001","article-title":"Advances on erythrocyte-mimicking nanovehicles to overcome barriers in biological microenvironments","volume":"170","author":"Castro","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1536\/ihj.14-322","article-title":"Platelet glycoprotein IIb\/IIIa inhibitor Tirofiban ameliorates cardiac reperfusion injury","volume":"56","author":"Chang","year":"2015","journal-title":"Int. Heart J."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.09.014","article-title":"Low-dose tissue plasminogen activator in acute ischemic stroke: A systematic review and meta-analysis","volume":"27","author":"Cheng","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1182\/blood-2010-07-297671","article-title":"Visualization and identification of the structures formed during early stages of fibrin polymerization","volume":"117","author":"Chernysh","year":"2011","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1160\/th04-11-0724","article-title":"Thrombolytic agents","volume":"93","author":"Collen","year":"2005","journal-title":"Thromb. Haemost."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.31635\/ccschem.020.202000470","article-title":"Principles and characteristics of polymerization-induced self-assembly with various polymerization techniques","volume":"3","author":"Cornel","year":"2021","journal-title":"CCS Chem."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1021\/acsnano.7b00594","article-title":"Organic semiconducting nanoparticles as efficient Photoacoustic agents for lightening early thrombus and monitoring thrombolysis in living mice","volume":"11","author":"Cui","year":"2017","journal-title":"ACS Nano"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1161\/circulationaha.112.000966","article-title":"Hydrogen peroxide promotes aging-related platelet Hyperactivation and thrombosis","volume":"127","author":"Dayal","year":"2013","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1002\/adma.201200607","article-title":"Platelet mimetic particles for targeting thrombi in flowing blood","volume":"24","author":"Doshi","year":"2012","journal-title":"Adv. Mater."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/nm782","article-title":"Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse","volume":"8","author":"Falati","year":"2002","journal-title":"Nat. Med."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature15218","article-title":"Nanotechnology Platelet mimicry","volume":"526","author":"Farokhzad","year":"2015","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1056\/nejm199201233260406","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes","volume":"326","author":"Fuster","year":"1992","journal-title":"New Eng. J. Med."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"7565","DOI":"10.1021\/acs.jmedchem.1c00264","article-title":"RGD-peptide functionalization affects the In vivo diffusion of a responsive Trimeric MRI contrast agent through interactions with Integrins","volume":"64","author":"Gambino","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"105108","DOI":"10.1016\/j.neuint.2021.105108","article-title":"Pseudoginsenoside-F11 ameliorates thromboembolic stroke injury in rats by reducing thromboinflammation","volume":"149","author":"Gao","year":"2021","journal-title":"Neurochem. Int."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"4797","DOI":"10.1021\/cr0680282","article-title":"Interparticle coupling effect on the surface plasmon resonance of gold nanoparticles: From theory to applications","volume":"107","author":"Ghosh","year":"2007","journal-title":"Chem. Rev."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.7536\/pc201019","article-title":"Nanocarriers modified by cell membrane and their applications in tumor immunotherapy","volume":"33","author":"Guan","year":"2021","journal-title":"Prog. Chem."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.11777\/j.issn1000-3304.2018.18079","article-title":"Trypsin-responsive near-infrared fluorescent\/magnetic resonance dual-imaging composite Nanospheres based on self-assembly","volume":"8","author":"Guo","year":"2018","journal-title":"Acta Polym. Sin."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2001647","DOI":"10.1002\/smll.202001647","article-title":"Thrombolytic agents: Nanocarriers in controlled release","volume":"16","author":"Hassanpour","year":"2020","journal-title":"Small"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"121111","DOI":"10.1016\/j.biomaterials.2021.121111","article-title":"Nanoparticles-mediated emerging approaches for effective treatment of ischemic stroke","volume":"277","author":"He","year":"2021","journal-title":"Biomaterials"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"371","DOI":"10.7536\/pc190906","article-title":"Polypyrrole and its Nanocomposites applied in Photothermal therapy","volume":"32","author":"Huang","year":"2020","journal-title":"Prog. Chem."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2019.02.033","article-title":"An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy","volume":"300","author":"Huang","year":"2019","journal-title":"J. Control. Release"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"719","DOI":"10.6023\/a20050162","article-title":"Challenges and perspective on ring-opening polymerization-induced self-assembly","volume":"78","author":"Jiang","year":"2020","journal-title":"Acta Chim. Sin."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.biomaterials.2017.11.047","article-title":"Thrombolytic therapy based on fucoidan-functionalized polymer nanoparticles targeting P-selectin","volume":"156","author":"Juenet","year":"2018","journal-title":"Biomaterials"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"6194","DOI":"10.1021\/acsnano.7b02308","article-title":"Fibrin-targeted and H2O2-responsive nanoparticles as a Theranostics for Thrombosed vessels","volume":"11","author":"Kang","year":"2017","journal-title":"ACS Nano"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1166\/jbn.2015.1943","article-title":"Nanomedicine for atherosclerosis: molecular imaging and treatment","volume":"11","author":"Karagkiozaki","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.2217\/nnm.14.99","article-title":"Tumor-targeting glycol chitosan nanoparticles as a platform delivery carrier in cancer diagnosis and therapy","volume":"9","author":"Lee","year":"2014","journal-title":"Nanomedicine"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1021\/acsabm.8b00644","article-title":"RGD modified protein-polymer conjugates for pH-triggered targeted thrombolysis","volume":"2","author":"Li","year":"2019","journal-title":"ACS Appl. Bio Matter."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1021\/acsnano.9b08587","article-title":"Platelet membrane biomimetic magnetic Nanocarriers for targeted delivery and in situ generation of nitric oxide in early ischemic stroke","volume":"14","author":"Li","year":"2020","journal-title":"ACS Nano"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nrcardio.2011.91","article-title":"Arterial thrombus formation in cardiovascular disease","volume":"8","author":"Lippi","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"10287","DOI":"10.1021\/acsami.0c20940","article-title":"Dual-targeting glycol chitosan\/heparin-decorated Polypyrrole nanoparticle for augmented Photothermal thrombolytic therapy","volume":"13","author":"Lu","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1158\/0008-5472.can-03-1054","article-title":"Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis","volume":"64","author":"Ludwig","year":"2004","journal-title":"Cancer Res."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules24183407","article-title":"Targeted delivery of plasminogen activators for thrombolytic therapy: An integrative evaluation","volume":"24","author":"Ma","year":"2019","journal-title":"Molecules"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nature06797","article-title":"Triggers, targets and treatments for thrombosis","volume":"451","author":"Mackman","year":"2008","journal-title":"Nature"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/brain\/awx111","article-title":"Regulatory T cells ameliorate tissue plasminogen activator-induced brain haemorrhage after stroke","volume":"140","author":"Mao","year":"2017","journal-title":"Brain"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/b978-1-4557-2296-9.00028-2","article-title":"Thrombolytic Therapy","volume":"28","author":"Marder","year":"2013","journal-title":"Cons. Hemo. Thrombosis."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1001\/jamaneurol.2015.0835","article-title":"Progress in intravenous thrombolytic therapy for acute stroke","volume":"72","author":"Marshall","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/CCM.0b013e3181c9cbd9","article-title":"Thrombotic risk factors: basic pathophysiology","volume":"38","author":"Martinelli","year":"2010","journal-title":"Crit. Care Med."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adhm.201700181","article-title":"Self-targeting, immune transparent plasma protein coated Nanocomplex for noninvasive Photothermal anticancer therapy","volume":"6","author":"Mi","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/pi.5702","article-title":"Saccharide-based nanocarriers for targeted therapeutic and diagnostic applications","volume":"68","author":"Mukwaya","year":"2019","journal-title":"Polym. Int."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1182\/blood-2011-07-369512","article-title":"T-PA-specific modulation of a human blood-brain barrier model involves plasmin-mediated activation of the rho kinase pathway in astrocytes","volume":"119","author":"Niego","year":"2012","journal-title":"Blood"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.biomaterials.2017.03.012","article-title":"Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis","volume":"128","author":"Pawlowski","year":"2017","journal-title":"Biomaterials"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1161\/01.str.0000083051.93319.28","article-title":"Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion","volume":"34","author":"Pfefferkorn","year":"2003","journal-title":"Stroke"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"E233","DOI":"10.1161\/str.0000000000000172","article-title":"2018 guidelines for the early Management of Patients With Acute Ischemic Stroke: A guideline for healthcare professionals From the American Heart Association\/American Stroke Association","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1056\/NEJMra1607714","article-title":"Management of Antithrombotic Therapy after acute coronary syndromes","volume":"384","author":"Rodriguez","year":"2021","journal-title":"New Engl. J. Med."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules23061256","article-title":"A gelatin hydrogel-containing Nano-organic PEI-Ppy with a Photothermal responsive effect for tissue engineering applications","volume":"23","author":"Satapathy","year":"2018","journal-title":"Molecules"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules25051039","article-title":"Glycosaminoglycans as tools to decipher the platelet tumor cell interaction: A focus on P-Selectin","volume":"25","author":"Schwarz","year":"2020","journal-title":"Molecules"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jconrel.2021.08.041","article-title":"Asymmetric flow field-flow fractionation (AF4) with fluorescence and multi-detector analysis for direct, real-time, size-resolved measurements of drug release from polymeric nanoparticles","volume":"338","author":"Shakiba","year":"2021","journal-title":"J. Control. Release"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1007\/s12274-016-1119-5","article-title":"Relief from vascular occlusion using photothermal ablation of thrombus with a multimodal perspective","volume":"9","author":"Singh","year":"2016","journal-title":"Nano Res."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nm1787","article-title":"Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke","volume":"14","author":"Su","year":"2008","journal-title":"Nat. Med."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"E88","DOI":"10.1161\/atvbaha.111.230631","article-title":"Fibrin clot structure and function A role in the pathophysiology of arterial and venous thromboembolic diseases","volume":"31","author":"Undas","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10118-018-2083-1","article-title":"Hybrid dextran-gadolinium Nano-suitcases as high-relaxivity MRI contrast agents","volume":"36","author":"Wang","year":"","journal-title":"Chin. J. Polym. Sci."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1080\/10717544.2018.1477857","article-title":"Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines","volume":"25","author":"Wang","year":"","journal-title":"Drug Deliv."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jconrel.2020.08.030","article-title":"Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy","volume":"328","author":"Wang","year":"2020","journal-title":"J. Control. Release"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.actbio.2020.10.015","article-title":"Functionalized polymeric hybrid micelles as an efficient nanotheranostic agent for thrombus imaging and thrombolysis","volume":"122","author":"Wang","year":"2021","journal-title":"Acta Biomater."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1021\/acsnano.9b01798","article-title":"Sequentially site-specific delivery of Thrombolytics and Neuroprotectant for enhanced treatment of ischemic stroke","volume":"13","author":"Xu","year":"2019","journal-title":"ACS Nano"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"20200145","DOI":"10.1002\/viw.20200145","article-title":"Intelligent antithrombotic nanomedicines: Progress, opportunities, and challenges","volume":"2","author":"Xu","year":"2021","journal-title":"Viewpoints"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1905145","DOI":"10.1002\/adma.201905145","article-title":"Engineered Nanoplatelets for targeted delivery of plasminogen activators to reverse thrombus in multiple mouse thrombosis models","volume":"32","author":"Xu","year":"2020","journal-title":"Adv. Mater."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/nsr\/nwz037","article-title":"Cell membrane-covered nanoparticles as biomaterials","volume":"6","author":"Xuan","year":"2019","journal-title":"Natl. Sci. Rev."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.2147\/jir.s327014","article-title":"Diagnostic and prognostic value of immune\/inflammation biomarkers for venous thromboembolism: is it reliable for clinical practice","volume":"14","author":"Xue","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1001\/jamaneurol.2014.1210","article-title":"Symptomatic Intracerebral hemorrhage in acute ischemic stroke After thrombolysis With intravenous recombinant tissue plasminogen activator A review of natural history and treatment","volume":"71","author":"Yaghi","year":"2014","journal-title":"JAMA Neurol."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.1074\/jbc.275.10.7249","article-title":"Probing chemical and conformational differences in the resting and active conformers of platelet integrin alpha(IIb)beta(3)","volume":"275","author":"Yan","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1039\/c9tb01834d","article-title":"Cyclic RGD functionalized liposomes targeted to activated platelets for thrombosis dual-mode magnetic resonance imaging","volume":"8","author":"Ye","year":"2020","journal-title":"J. Mat. Chem."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"16076","DOI":"10.1021\/acsnano.1c04753","article-title":"Targeted treatment of ischemic stroke by bioactive nanoparticle-derived reactive oxygen species responsive and inflammation-resolving Nanotherapies","volume":"15","author":"Yuan","year":"2021","journal-title":"ACS Nano"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/1061186x.2017.1365874","article-title":"Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke","volume":"26","author":"Zamanlu","year":"2018","journal-title":"J. Drug Target."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"120297","DOI":"10.1016\/j.biomaterials.2020.120297","article-title":"Nanomedicine progress in thrombolytic therapy","volume":"258","author":"Zenych","year":"2020","journal-title":"Biomaterials"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"121102","DOI":"10.1016\/j.biomaterials.2021.121102","article-title":"Fucoidan-functionalized polysaccharide submicroparticles loaded with alteplase for efficient targeted thrombolytic therapy","volume":"277","author":"Zenych","year":"2021","journal-title":"Biomaterials"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41467-017-02251-3","article-title":"Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/advs.201901378","article-title":"Metal-organic-framework-derived carbon nanostructures for site-specific dual-modality Photothermal\/photodynamic thrombus therapy","volume":"6","author":"Zhang","year":"2019","journal-title":"Adv. Sci."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nantod.2020.100986","article-title":"Biomimetic fibrin-targeted and H2O2-responsive nanocarriers for thrombus therapy","volume":"35","author":"Zhao","year":"","journal-title":"Nano Today"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1039\/d0bm02125c","article-title":"Hydrogen peroxide-responsive platelet membrane-coated nanoparticles for thrombus therapy","volume":"9","author":"Zhao","year":"2021","journal-title":"Biomater. Sci."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"120200","DOI":"10.1016\/j.biomaterials.2020.120200","article-title":"Emerging nanotherapeutics for antithrombotic treatment","volume":"255","author":"Zhao","year":"","journal-title":"Biomaterials"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/jbm.a.36803","article-title":"Synthesis and evaluation of a novel nanoparticle carrying urokinase used in targeted thrombolysis","volume":"108","author":"Zhong","year":"2020","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7150\/thno\/v01p0058","article-title":"Radiolabeled cyclic RGD peptides as radiotracers for imaging tumors and thrombosis by SPECT","volume":"1","author":"Zhou","year":"2011","journal-title":"Theranostics"}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.763085\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T18:18:37Z","timestamp":1638382717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.763085\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":84,"alternative-id":["10.3389\/fphys.2021.763085"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2021.763085","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,30]]},"article-number":"763085"}}